FDA just approved the drug for asthma this week. PI- McQuaid Read Full Article Category: NewsBy PulmonixJune 28, 2018Post navigationPreviousPrevious post:New COPD Triple InhalerNextNext post:LeBauer HealthCare Selected for Prestigious Pulmonary Fibrosis NetworkRelated PostsPhase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary FibrosisMay 21, 2026Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER StudyMay 21, 2026PULMONIX VOLUNTEERS WITH THE KELLIN FOUNDATION TO SUPPORT FAMILIES IN NEEDJuly 18, 2025PULMONIX NAMED FINALIST FOR TRIAD BUSINESS JOURNAL’S BEST PLACES TO WORKMay 29, 2025
Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER StudyMay 21, 2026
